Evidence map›Paper›PMID 36211426›Full record

ArticleFrontiers in immunology2022

Targeting the innate repair receptor axis

Sophie Dennhardt, Wiebke Pirschel, Bianka Wissuwa, Diana Imhof, Christoph Daniel, Jan T Kielstein, Isabel Hennig-Pauka, Kerstin Amann, Florian Gunzer, Sina M Coldewey

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Sophie DennhardtDepartment of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Wiebke PirschelDepartment of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Bianka WissuwaDepartment of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Diana ImhofPharmaceutical Biochemistry and Bioanalytics, Pharmaceutical Institute, University of Bonn, Bonn, Germany.
Christoph DanielDepartment of Nephropathology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany.
Jan T KielsteinMedical Clinic V, Nephrology | Rheumatology | Blood Purification, Academic Teaching Hospital Braunschweig, Braunschweig, Germany.
Isabel Hennig-PaukaField Station for Epidemiology, University of Veterinary Medicine Hannover, Bakum, Germany.
Kerstin AmannDepartment of Nephropathology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany.
Florian GunzerDepartment of Hospital Infection Control, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
Sina M ColdeweyDepartment of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Jena University Hospital · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEKlinikum Braunschweig · DETU Dresden · DEUniversity of Bonn · DEUniversity of Veterinary Medicine Hannover, Foundation · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemolytic-uremic syndrome (HUS) can occur as a systemic complication of infections with Shiga toxin (Stx)-producing

Indexed as

ErythropoietinHemolytic-Uremic SyndromeShiga-Toxigenic Escherichia coliAnimalsCytokine Receptor Common beta SubunitHumansMiceOligopeptidesReceptors, ErythropoietinShiga ToxinsSwinecibinetideCytokine Receptor Common beta SubunitErythropoietininnate repair receptorOligopeptidesReceptors, ErythropoietinShiga Toxinserythropoietinhemolytic-uremic syndromemicemicroangiopathic hemolytic anemiapyroglutamate helix B surface peptideshiga toxinthrombotic microangiopathy

Identifiers

PMID36211426
PMCPMC9537456
OpenAlexW4296830334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.